Ascentage Pharma Group International (AAPG) Minority Interest (2023 - 2024)
Ascentage Pharma Group International (AAPG) posted quarterly Minority Interest of $1.4 million for Q4 2024, down 2.19% year-on-year from $1.4 million in Q1 2024, and down 2.19% on a QoQ basis from $1.4 million in Q4 2023.
Ascentage Pharma Group International (AAPG) Minority Interest (2023 - 2024) Analysis & Trends
Ascentage Pharma Group International (AAPG) has reported Minority Interest for 2 consecutive years, with $1.4 million the latest figure, recorded in Q4 2024.
- Quarterly Minority Interest fell 2.19% year-over-year to $1.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.4 million (down 2.19% YoY) and the FY2024 annual result came in at $1.4 million, down 5.5% from the prior year.
- Minority Interest fell to $1.4 million in Q4 2024 per AAPG's latest filing, from $1.4 million in the prior quarter.
- Over the last five years, Minority Interest for AAPG reached as high as $1.4 million in Q4 2023 and fell as low as $1.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascentage Pharma Group International | 6.88 Bn | 6.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 1.42 Mn |